257 related articles for article (PubMed ID: 16857737)
21. TAK1 knockdown enhances lipopolysaccharide-induced secretion of proinflammatory cytokines in myeloid cells via unleashing MEKK3 activity.
Li K; Wang M; Hu Y; Xu N; Yu Q; Wang Q
Cell Immunol; 2016 Dec; 310():193-198. PubMed ID: 27671672
[TBL] [Abstract][Full Text] [Related]
22. TAK1: Another mesh in the NF-κB - JNK controlled network causing hepatocellular carcinoma.
Greten FR
J Hepatol; 2011 Sep; 55(3):721-723. PubMed ID: 21601601
[TBL] [Abstract][Full Text] [Related]
23. Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB.
Suzuki S; Singhirunnusorn P; Mori A; Yamaoka S; Kitajima I; Saiki I; Sakurai H
J Biol Chem; 2007 Aug; 282(35):25177-81. PubMed ID: 17626013
[TBL] [Abstract][Full Text] [Related]
24. Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.
Moreno-García ME; Sommer K; Rincon-Arano H; Brault M; Ninomiya-Tsuji J; Matesic LE; Rawlings DJ
Mol Cell Biol; 2013 Mar; 33(6):1149-63. PubMed ID: 23297344
[TBL] [Abstract][Full Text] [Related]
25. Lack of TAK1 in dendritic cells inhibits the contact hypersensitivity response induced by trichloroethylene in local lymph node assay.
Yao P; Hongqian C; Qinghe M; Lanqin S; Jianjun J; Xiaohua Y; Xuetao W; Weidong H
Toxicol Appl Pharmacol; 2016 Sep; 307():72-80. PubMed ID: 27473013
[TBL] [Abstract][Full Text] [Related]
26. A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation.
Schuman J; Chen Y; Podd A; Yu M; Liu HH; Wen R; Chen ZJ; Wang D
Blood; 2009 May; 113(19):4566-74. PubMed ID: 19196865
[TBL] [Abstract][Full Text] [Related]
27. The lack of NF-kappa B transactivation and PKC epsilon expression in CD4(+)CD8(+) thymocytes correlates with negative selection.
Simon AK; Auphan N; Pophillat M; Boyer C; Ghosh S; Rincón M; Flavell RA; Schmitt-Verhulst AM
Cell Death Differ; 2000 Dec; 7(12):1253-62. PubMed ID: 11175263
[TBL] [Abstract][Full Text] [Related]
28. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage.
Yang Y; Xia F; Hermance N; Mabb A; Simonson S; Morrissey S; Gandhi P; Munson M; Miyamoto S; Kelliher MA
Mol Cell Biol; 2011 Jul; 31(14):2774-86. PubMed ID: 21606198
[TBL] [Abstract][Full Text] [Related]
29. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
Kaur S; Wang F; Venkatraman M; Arsura M
J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589
[TBL] [Abstract][Full Text] [Related]
30. WNK1-TAK1 signaling suppresses lipopolysaccharide-induced cytokine production and classical activation in macrophages.
Arai Y; Asano K; Mandai S; Ando F; Susa K; Mori T; Nomura N; Rai T; Tanaka M; Uchida S; Sohara E
Biochem Biophys Res Commun; 2020 Dec; 533(4):1290-1297. PubMed ID: 33046244
[TBL] [Abstract][Full Text] [Related]
31. TAK1, more than just innate immunity.
Dai L; Aye Thu C; Liu XY; Xi J; Cheung PC
IUBMB Life; 2012 Oct; 64(10):825-34. PubMed ID: 22941947
[TBL] [Abstract][Full Text] [Related]
32. Role of endogenous annexin-A1 in the regulation of thymocyte positive and negative selection.
Paschalidis N; Huggins A; Rowbotham NJ; Furmanski AL; Crompton T; Flower RJ; Perretti M; D'Acquisto F
Cell Cycle; 2010 Feb; 9(4):784-93. PubMed ID: 20139728
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel induces apoptosis through the TAK1-JNK activation pathway.
Yu-Wei D; Li ZS; Xiong SM; Huang G; Luo YF; Huo TY; Zhou MH; Zheng YW
FEBS Open Bio; 2020 Aug; 10(8):1655-1667. PubMed ID: 32594651
[TBL] [Abstract][Full Text] [Related]
34. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.
Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T
Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931
[TBL] [Abstract][Full Text] [Related]
35. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.
Zhou J; Qiu T; Wang T; Chen Z; Ma X; Zhang L; Zou J
Clin Sci (Lond); 2019 Jan; 133(2):335-349. PubMed ID: 30622220
[TBL] [Abstract][Full Text] [Related]
36. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
[TBL] [Abstract][Full Text] [Related]
37. TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-κB.
Wi SM; Moon G; Kim J; Kim ST; Shim JH; Chun E; Lee KY
J Biol Chem; 2014 Dec; 289(51):35205-14. PubMed ID: 25371197
[TBL] [Abstract][Full Text] [Related]
38. Ablation of Tak1 in osteoclast progenitor leads to defects in skeletal growth and bone remodeling in mice.
Qi B; Cong Q; Li P; Ma G; Guo X; Yeh J; Xie M; Schneider MD; Liu H; Li B
Sci Rep; 2014 Nov; 4():7158. PubMed ID: 25418008
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function.
Wang Y; Huang G; Vogel P; Neale G; Reizis B; Chi H
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):E343-52. PubMed ID: 22308391
[TBL] [Abstract][Full Text] [Related]
40. ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction.
Mochida Y; Takeda K; Saitoh M; Nishitoh H; Amagasa T; Ninomiya-Tsuji J; Matsumoto K; Ichijo H
J Biol Chem; 2000 Oct; 275(42):32747-52. PubMed ID: 10921914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
